Egr-1 Mediates Transcriptional Repression of COL2A1Promoter Activity by Interleukin-1β*
暂无分享,去创建一个
Linda J. Sandell | Philip E. Auron | M. Goldring | L. Sandell | P. Auron | Mary B. Goldring | L. Tan | B. Choy | Haibing Peng | Lujian Tan | Hai-bing Peng | Makoto Osaki | Bob K. Choy | M. Osaki
[1] V. Lefebvre,et al. Use of a New Rat Chondrosarcoma Cell line to Delineate a 119-Base Pair Chondrocyte-specific Enhancer Element and to Define Active Promoter Segments in the Mouse Pro-α1(II) Collagen Gene (*) , 1995, The Journal of Biological Chemistry.
[2] Eileen D. Adamson,et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.
[3] J. Milbrandt,et al. Growth and Differentiation Proceeds Normally in Cells Deficient in the Immediate Early Gene NGFI-A (*) , 1995, The Journal of Biological Chemistry.
[4] Xinmin Cao,et al. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1 , 1998, Oncogene.
[5] L. Sandell,et al. The human type II procollagen gene: identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron. , 1990, Genomics.
[6] J. Milbrandt,et al. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. , 1998, The Journal of clinical investigation.
[7] E. Vuorio,et al. Conservation of the sizes of 53 introns and over 100 intronic sequences for the binding of common transcription factors in the human and mouse genes for type II procollagen (COL2A1). , 1995, Biochemical Journal.
[8] Y. Tan,et al. Casein Kinase II Associates with Egr-1 and Acts as a Negative Modulator of Its DNA Binding and Transcription Activities in NIH 3T3 Cells* , 1996, The Journal of Biological Chemistry.
[9] Y. Tan,et al. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. , 1992, The Journal of biological chemistry.
[10] K. Kent,et al. Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II Receptor* , 2000, The Journal of Biological Chemistry.
[11] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[12] P. Krebsbach,et al. Collagen II promoter and enhancer interact synergistically through Sp1 and distinct nuclear factors. , 1995, DNA and cell biology.
[13] M. Goldring,et al. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide , 1991, The Journal of cell biology.
[14] M. Goldring,et al. The role of the chondrocyte in osteoarthritis. , 2000, Arthritis and rheumatism.
[15] J. Duthie,et al. Arthritis and Allied Conditions. A Textbook of Rheumatology , 1973 .
[16] J. Rubenstein,et al. Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. , 2001, DNA and cell biology.
[17] D. Edwards,et al. Protein synthesis inhibitors differentially superinduce c‐fos and c‐jun by three distinct mechanisms: lack of evidence for labile repressors. , 1992, The EMBO journal.
[18] K. Fukuo,et al. Transcriptional suppression by interleukin‐1 and interferon‐γ of type II collagen gene expression in human chondrocytes , 1994 .
[19] M. Olive,et al. Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins , 2000, Molecular and Cellular Biology.
[20] S. Murakami,et al. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Suva,et al. Retinoic acid increases zif268 early gene expression in rat preosteoblastic cells , 1991, Molecular and cellular biology.
[22] S. Philipsen,et al. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. , 1999, Nucleic acids research.
[23] L. Ala‐Kokko,et al. SP3 Represses the SP1-mediated Transactivation of the HumanCOL2A1 Gene in Primary and De-differentiated Chondrocytes* , 2001, The Journal of Biological Chemistry.
[24] S. Kumar,et al. Differential expression of egr-1 in osteoarthritic compared to normal adult human articular cartilage. , 2000, Osteoarthritis and cartilage.
[25] I. Adcock,et al. Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.
[26] N. Fukui,et al. CCAAT/Enhancer-binding Proteins β and δ Mediate the Repression of Gene Transcription of Cartilage-derived Retinoic Acid-sensitive Protein Induced by Interleukin-1β* , 2002, The Journal of Biological Chemistry.
[27] J. Tyler,et al. Inhibition of cartilage proteoglycan synthesis by interleukin I. , 1988, Biochemical and biophysical research communications.
[28] T. Osborne,et al. YY1 Is a Positive Regulator of Transcription of theCol1a1 Gene* , 2001, The Journal of Biological Chemistry.
[29] S. Jimenez,et al. Detection and Characterization of Sp1 Binding Activity in Human Chondrocytes and Its Alterations during Chondrocyte Dedifferentiation* , 1997, The Journal of Biological Chemistry.
[30] A. McMahon,et al. Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. , 1990, Development.
[31] B. Crombrugghe,et al. Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .
[32] R. Boltz,et al. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. , 1998, The Journal of biological chemistry.
[33] Amyj . Williams,et al. Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury , 1996, Science.
[34] L. Khachigian,et al. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. , 1999, The American journal of pathology.
[35] J. Martel-Pelletier,et al. Suppression of tumor necrosis factor (TNF-alpha) gene expression by prostaglandin E(2). Role Of early growth response protein-1 (Egr-1). , 1999, Osteoarthritis and cartilage.
[36] D. Hallahan,et al. c-jun and Egr-1 Participate in DNA Synthesis and Cell Survival in Response to Ionizing Radiation Exposure (*) , 1995, The Journal of Biological Chemistry.
[37] V. Lefebvre,et al. Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α* , 2000, The Journal of Biological Chemistry.
[38] L. Crofford,et al. Critical role of C/EBPδ and C/EBPβ factors in the stimulation of the cyclooxygenase‐2 gene transcription by interleukin‐1β in articular chondrocytes , 2000 .
[39] L. Peltonen,et al. Structural analysis of the regulatory elements of the type-II procollagen gene. Conservation of promoter and first intron sequences between human and mouse. , 1992, Biochemical Journal.
[40] L. Sandell. Genes and gene regulation of extracellular matrix proteins: an introduction. , 1996, Connective tissue research.
[41] T. Minowa,et al. Negative modulator of the rat D2 dopamine receptor gene. , 1994, The Journal of biological chemistry.
[42] R. Datla,et al. Expression of human N-myristoyltransferase inEscherichia coli. Comparison with N-myristoyltransferases expressed in different tissues , 1996, Molecular and Cellular Biochemistry.
[43] R. Loeser,et al. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for α1β1 and α2β1 integrins in mediating chondrocyte adhesion to types II and VI collagen , 2000 .
[44] M. Centrella,et al. Multiple and Essential Sp1 Binding Sites in the Promoter for Transforming Growth Factor-β Type I Receptor* , 1997, The Journal of Biological Chemistry.
[45] J. Tyler,et al. Synthesis of type II collagen is decreased in cartilage cultured with interleukin 1 while the rate of intracellular degradation remains unchanged. , 1988, Collagen and related research.
[46] Ruo-Pan Huang,et al. The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1* , 1999, The Journal of Biological Chemistry.
[47] S. Madden,et al. Transcriptional repression mediated by the WT1 Wilms tumor gene product. , 1991, Science.
[48] P. Dijke,et al. Interaction between GC Box Binding Factors and Smad Proteins Modulates Cell Lineage-specific α2(I) Collagen Gene Transcription* , 2001, The Journal of Biological Chemistry.
[49] L. Ala‐Kokko,et al. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. , 2000, The Journal of biological chemistry.
[50] A. Rizzino,et al. Identification of the Transactivation Domain of the Transcription Factor Sox-2 and an Associated Co-activator* , 2000, The Journal of Biological Chemistry.
[51] T. Libermann,et al. ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.
[52] V. Sukhatme,et al. A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1 , 1993, Molecular and cellular biology.
[53] W. Koopman. Arthritis and allied conditions;: A textbook of rheumatology , 1972 .
[54] W. Horton,et al. The Transcription Factor δEF1 Is Inversely Expressed with Type II Collagen mRNA and Can Repress Col2a1 Promoter Activity in Transfected Chondrocytes* , 2000, The Journal of Biological Chemistry.
[55] Véronique Lefebvre,et al. A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.
[56] D. Chasman,et al. Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro , 1989, Molecular and cellular biology.
[57] V. Harley,et al. Molecular mechanisms of SOX9 action. , 2000, Molecular genetics and metabolism.
[58] Ruo-Pan Huang,et al. UV irradiation upregulates Egr‐1 expression at transcription level , 1999, Journal of cellular biochemistry.
[59] J. Arbiser,et al. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. , 2000, Arthritis and rheumatism.
[60] G. Lyons,et al. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. , 1995, Development.
[61] W. Horton,et al. Identification of a cis-acting sequence in the collagen II enhancer required for chondrocyte expression and the binding of a chondrocyte nuclear factor. , 1991, The Journal of biological chemistry.
[62] D. Mercola,et al. The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251* , 2000, The Journal of Biological Chemistry.
[63] J. Glowacki,et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. , 1994, The Journal of clinical investigation.
[64] M. Beato,et al. Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.
[65] V. Rangnekar,et al. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6 , 1995, Molecular and cellular biology.
[66] R. Gay,et al. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. , 1994, Journal of immunology.
[67] K. Cheah,et al. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2. , 2003, The Biochemical journal.
[68] M. Mayo,et al. Basic fibroblast growth factor transcriptional autoregulation requires EGR-1 , 1997, Oncogene.
[69] S. Krane,et al. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. , 1988, The Journal of clinical investigation.
[70] J. Drazen,et al. cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). , 1998, The Biochemical journal.
[71] K. Cheah,et al. Different cis-Regulatory DNA Elements Mediate Developmental Stage- and Tissue-specific Expression of the Human COL2A1 Gene in Transgenic Mice , 1998, The Journal of cell biology.
[72] S. Apte,et al. Egr-1 Mediates Extracellular Matrix-driven Transcription of Membrane Type 1 Matrix Metalloproteinase in Endothelium* , 1999, The Journal of Biological Chemistry.
[73] P. Auron,et al. The interleukin 1 receptor: ligand interactions and signal transduction. , 1998, Cytokine & growth factor reviews.
[74] W. Horton,et al. The control of expression of type II collagen: relevance to cartilage disease. , 1992, DNA and cell biology.
[75] K. Fitzgerald,et al. Characterization of CD44 induction by IL-1: a critical role for Egr-1. , 1999, Journal of immunology.
[76] E. Silverman,et al. Pathways of Egr-1-mediated gene transcription in vascular biology. , 1999, The American journal of pathology.